Phase 2 Study of Pembrolizumab Combined With Chemoradiation Therapy in Anaplastic Thyroid Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 04 May 2018
At a glance
- Drugs Pembrolizumab (Primary) ; Docetaxel; Doxorubicin
- Indications Thyroid cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 27 Apr 2018 Status changed from suspended to active, no longer recruiting.
- 14 Feb 2018 Status changed from recruiting to suspended.